(Q61980054)

English

Bortezomib (Velcade) Post Allogenic Peripheral Blood Stem Cell Transplantation for Myeloma

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Phase II Trial of Bortezomib (Velcade) After Allogenic Peripheral Blood Stem Cell or Bone Marrow Transplantation for Patients With Multiple Myeloma (English)

0 references

medical condition

multiple myeloma

0 references

sponsor

The University of Texas MD Anderson Cancer Center

0 references

country

United States of America

0 references

start time

January 2004

0 references

end time

August 2007

0 references

number of participants

8

0 references

research intervention

bortezomib

0 references

clinical trial phase

phase II clinical trial

0 references

research site

University of Texas at Houston Police Department

0 references

research subject recruitment status

completed

0 references

maximum age

70 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00504634

0 references

(Q61980054)

Bortezomib (Velcade) Post Allogenic Peripheral Blood Stem Cell Transplantation for Myeloma

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)